業績

Aika Miya, Akinobu Nakamura, Hiroshi Nomoto, Hiraku Kameda, Tatsuya Atsumi Positive association between the proinsulin-to-C-peptide ratio and prolonged hyperglycemic time in type 2 diabetes Endocrine Journal, in press.

IF=2.0

  • 2024
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Sugawara M, Osanami A, Asai Y, Ogawa Y, Nagahata K, Nakamura H, Suzuki C, Kanda M, Takahashi H.

Successful treatment of ANCA-associated glomerulonephritis following pulmonary alveolar proteinosis by rituximab and avacopan.

Rheumatology, in press.

IF: 5.5

  • 2024
  • 膠原病グループ
  • 欧文論文/症例報告

Iesaka H, Kameda H, Miya A, Nomoto H, Cho KY, Nakamura A, Abe T, Shinohara N, Atsumi T Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and

ipilimumab: A case report

Medicine, in press

IF: 1.6

  • 2023
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Izumihara R, Nomoto H*, Kito K, Yamauchi Y, Omori K, Shibayama Y, Yanagiya S, Miya A, Kameda H, Cho KY, Nagai S, Sakuma I, Nakamura A, Atsumi T.

Switching from conventional fibrates to pemafibrate has beneficial effects on the renal function of diabetic subjects with chronic kidney disease.

Diabetes Metab J, in press.

IF: 5.9, 5-Y IF: 5.4

  • 2023
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Sho Furusawa, Hiroshi Nomoto,  Hiroki Yokoyama,  Yuka Suzuki, Atsushi Tsuzuki, Kiyohiko Takahashi, Aika Miya, Hiraku Kameda,  Kyu Yong Cho, Jun Takeuchi, So Nagai, Shinji Taneda, Yoshio Kurihara, Akinobu Nakamura, Tatsuya Atsumi.

Glycemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: a multicenter, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study) Diabetes, Obesity and Metabolism, in press

IF=5.8

  • 2023
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Koga R, Maehara T, Aoyagi R, Munemura R, Murakami Y, Doi A, Kono M, Yamamoto H, Niiro H, Kiyoshima T, Tomonaga T, Tanabe M, Nakano T, Matsukuma Y, Kawano M, Kawano S, Stone JH, Pillai S, Nakamura S.

Granzyme K- and amphiregulin-expressing cytotoxic T cells and activated extrafollicular B cells are potential drivers of IgG4-related disease Journal of Allergy and Clinical Immunology, in press

IF=14.2

  • 2023
  • 膠原病グループ
  • 欧文論文/原著

the prize in poster presentation for APSTH 2023 守谷 悠先生

  • 2023
  • 膠原病グループ
  • 受賞

Akinobu Nakamura, Aika Miya, Yuka Suzuki, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, So Nagai, Tatsuya Atsumi.

Positive association between proinsulin and fatty liver index in people with type 2 diabetes.

Endocr J, in press.

IF: 2.0

  • 2023
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nomoto H, Kito K, Iesaka H, Handa T, Yanagiya S, Miya A, Kameda H, Cho KY, Takeuchi J, Nagai S, Sakuma I, Nakamura A, Atsumi T.

Preferable Effects Of Pemafibrate On Liver Function And Fibrosis In Subjects With Type 2 Diabetes Complicated With Liver Damage Diabetol Metab Syndr, in press IF= 4.7

  • 2023
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Sofue H, Kida T, Hirano A, Omura S, Kadoya M, Nakagomi D, Abe Y, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida T, Endo K, Hirata S, Matsui K, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Shimojima Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Ito-Ihara T, Yajima N, Kawaguchi T, Fujioka K, Fujii W, Seno T, Wada M, Kohno M, Kawahito Y.

Optimal Dose of Intravenous Cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: a retrospective cohort study of J-CANVAS.

Modern Rheumatology. in press.

IF: 2.2

  • 2023
  • 膠原病グループ
  • 欧文論文/原著